文献速递呼吸道感染肺栓塞与肺血管病

识别COVID-19感染后出院并发症风险患者

Identifying patients at risk of post-discharge complications related to COVID-19 infection.
PubMed 文献 · Thorax · 2021-02-04

该研究对英国一家医院200例COVID-19出院患者进行4-6周结构化门诊评估,发现40%存在心肺源性呼吸困难,包括持续性肺实质异常、肺栓塞和心脏并发症,ICU患者风险更高。

要点

  • COVID-19出院后4周约34%幸存者有持续症状
  • 40%随访患者呼吸困难可归因于心肺原因
  • ICU患者出现显著心肺原因的风险比为2.8

核心结论

  • COVID-19出院患者中约40%的呼吸困难可归因于心肺原因,ICU患者风险更高。

研究设计与样本

  • 单中心回顾性队列,报告英国一家医院初始200例COVID-19住院患者的早期随访数据。
  • 设计结构化门诊临床评估方案,呈现出院后4-6周首批200例患者结局。

主要发现

  • 出院后4周,957例幸存者中321例(34%)有持续症状。
  • 200例随访患者中80例(40%)发现呼吸困难的心肺原因,包括持续性肺实质异常64例、肺栓塞4例、心脏并发症8例。
  • 上述发现见于ICU和非ICU患者,但ICU患者呼吸困难有显著心肺原因的风险比为2.8(95% CI 1.5至5.1)。

临床怎么用

  • 对COVID-19出院患者,尤其ICU存活者,应在出院后4-6周进行结构化门诊评估以识别心肺并发症。

局限性

  • 单中心研究,样本来自初始200例住院患者,随访时间仅4-6周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SARS-CoV-2 infection is a multisystem disease with post-discharge sequelae. We report early follow-up data from one UK hospital of the initial 200 hospital inpatients with slow recovery from the condition. At 4 weeks post-discharge, 321/957 survivors (34%) had persistent symptoms. A structured outpatient clinical assessment protocol was designed, and outcomes from the first 200 patients seen 4-6 weeks post-discharge are presented here. In 80/200 (40%), we identified at follow-up a cardiorespiratory cause of breathlessness, including persistent parenchymal abnormality (64 patients), pulmonary embolism (four patients) and cardiac complications (eight patients). These findings occurred both in patients who had intensive care unit (ICU) admissions and those who had been managed on the ward, although patients requiring ICU admissions were more likely to have a significant cardiorespiratory cause found for their breathlessness, risk ratio 2.8 (95% CI 1.5 to 5.1).

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Hall J, Myall K, Lam JL, et al. Identifying patients at risk of post-discharge complications related to COVID-19 infection. Thorax. 2021. PMID: 33542090. doi:10.1136/thoraxjnl-2020-215861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。